PLoS ONE · 2014 · 52 citations · 20 references
Life SciencesBiochemistryEndocrinologyCell SignalingInflammationSignal TransductionAdipose TissueCytokine BiologyCytokine RegulationCytokine SignalingInflammatory MediatorsInflammatory SignalingAdipocyte BiologyAdipocyte Insulin SignalingCytokine Secretion RegulationInflammatory Cytokine SecretionInsulin ActionInsulin SignalingMonocyte Chemoattractant Protein-1Secreted Frizzled-related Proteins
Secreted frizzled-related protein 5 (Sfrp5) is an adipokine with anti-inflammatory and insulin-sensitizing properties in mice. However, the mechanism of Sfrp5 action, especially in humans, is largely unknown. Therefore, cytokine release and insulin signaling were analyzed to investigate the impact of Sfrp5 on inflammation and insulin signaling in primary human adipocytes and skeletal muscle cells (hSkMC). Sfrp5 neither affected interleukin (IL)-6, monocyte chemoattractant protein-1 (MCP-1) and adiponectin release from human adipocytes, nor IL-6 and IL-8 release from hSkMC. In tumor necrosis factor (TNF) α-treated adipocytes, Sfrp5 reduced IL-6 release by 49% (p<0.05), but did not affect MCP-1 and adiponectin release. In MCP-1-treated hSkMC, Sfrp5 did not affect cytokine secretion. In untreated adipocytes, Sfrp5 decreased the insulin-mediated phosphorylation of Akt-Ser473, Akt-Thr308, GSK3α-Ser21 and PRAS40-Thr246 by 34% (p<0.01), 31% (p<0.05), 37% (p<0.05) and 34% (p<0.01), respectively, and the stimulation of glucose uptake by 25% (p<0.05). Incubation with TNFα increased the phosphorylation of JNK and NFκB, and impaired insulin signaling. When Sfrp5 and TNFα were combined, there was no additional effect on insulin signaling and JNK phosphorylation, but phosphorylation of NFκB was reversed to basal levels. Sfrp5 had no effect on insulin signaling in untreated or in MCP-1 treated hSkMC. Thus, Sfrp5 lowered IL-6 release and NFκB phosphorylation in cytokine-treated human adipocytes, but not under normal conditions, and decreased insulin signaling in untreated human adipocytes. Sfrp5 did not act on hSkMC. Therefore, the cellular actions of Sfrp5 seem to depend on the type of tissue as well as its inflammatory and metabolic state.
20
Vincent Aguirre, Eric D. Werner, Jodel Giraud et al. · Journal of Biological Chemistry · 2002 · 985 citations · Full text
Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in Obesity
Noriyuki Ouchi, Akiko Higuchi, Koji Ohashi et al. · Science · 2010 · 493 citations · Full text
Changes in Gene Expression Foreshadow Diet-Induced Obesity in Genetically Identical Mice
Robert A. Koza, Larissa Nikonova, Jessica C. Hogan et al. · PLoS Genetics · 2006 · 365 citations · Full text
Life Sciences, Genetics, Physiology +14